John O. Schorge, MD
Associate Professor
Massachusetts General Hospital/Harvard University
OB/GYN
55 Fruit Street
Boston,
MA
USA
02114
Biographical Sketch: I currently serve as Chief of GYN Oncology at Mass General and have previously presented numerous times at the SGO Annual Mtg
Papers:
68 - Featured Poster
Primary debulking surgery or neoadjuvant chemotherapy: what is the optimal treatment approach for obese patients with ovarian/fallopian tube/primary peritoneal carcinoma?
170 - Poster Session A
Distribution of ovarian cancer recurrence following intravenous (IV) and intraperitoneal (IP) adjuvant chemotherapy after upfront cytoreductive surgery
225 - Poster Session A
Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction
249 - Poster Session A
Risk of second primary breast cancer among women with epithelial ovarian cancer compared to fallopian tube cancer
288 - Poster Session A
Dual HER2 targeting impedes growth of HER2 gene-amplified uterine papillary serous carcinoma xenografts
327 - Poster Session A
Prognostic factors of lymph node involvement in endometrioid endometrial cancer: a SEER analysis
387 - Poster Session B
Management and outcomes for elderly women with vulvar cancer over time
410 - Poster Session B
Management of advanced epithelial ovarian cancer in the elderly